CDC
WASHINGTON - CDC has confirmed the influenza neuraminidase N1 subtype of the U.S. case of human avian influenza A(H5) reported last week by genetic sequencing. Genetic characterization is ongoing and final data will be made publicly available in GenBankexternal icon as soon as available.
Background. A person has tested positive for avian influenza A(H5) virus (H5 bird flu) in the U.S., as reported by Colorado and confirmed by CDC. This case occurred in a person who had direct exposure to poultry and was involved in the culling (depopulating) of poultry with presumptive H5N1 bird flu. The patient reported fatigue for a few days as their only symptom and has since recovered. The patient is being isolated and treated with the influenza antiviral drug oseltamivir.
Click here to learn more.
Source: CDC.gov
Latest from Quality Assurance & Food Safety
- FDA, CDC Investigate Salmonella Outbreak Linked to Live It Up Dietary Supplement Powder
- USDA FSIS Announces New Deputy Administrator of Field Operations
- ProVeg Incubator Launches Fast-Track to Impact Program for Alt-Protein Startups
- Kerry Releases 2026 Global Taste Charts
- FDA Shares Australia Certificate Requirements for Bivalve Molluscs and Related Products
- FDA Announces Update from CFIA on Certificate Requirements for Certain Meat, Poultry Products
- NIMA Partners Introduces the Next-Generation NIMA Gluten Sensor
- IFT to Host Community Conversation on Dietary Guidelines for Americans, 2025-2030 Report
